News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
The FDA Oncology has approved the first T cell receptor gene therapy for adults with metastatic synovial sarcoma – SITC
Aug 4, 2024, 09:29

The FDA Oncology has approved the first T cell receptor gene therapy for adults with metastatic synovial sarcoma – SITC

Society for Immunotherapy of Cancer (SITC) shared on X:

“The FDA Oncology has approved the first T cell receptor gene therapy for adults with metastatic synovial sarcoma. This cutting-edge treatment is a significant advancement in cancer treatment. Learn more.”

Source: SITC/X

cancer cancer treatment FDA Oncology metastatic synovial sarcoma OncoDaily Oncology SITC Society for Immunotherapy of Cancer
Special Coverage
Voices
Sep 7, 2025, 05:24
Christian Rolfo: Amazing IASLC Academy 2025!
Voices
Sep 7, 2025, 05:18
Shreyas Kalantri: Two of My Posters Are Being Presented at WCLC25
Voices
Sep 7, 2025, 05:14
30 Days Until the Jimmy Fund Walk 2025 - Florez Lab
Voices
Sep 7, 2025, 05:09
Roberto Borea: Umberto Malapelle Opens the Plenary at WCLC25
Voices
Sep 7, 2025, 05:05
Rita Ahmad: Sharing Exciting Updates on Immunotherapy in IBCL
Voices
Sep 7, 2025, 04:54
Herbert Loong: The ASCO International Affairs Committee 2025-26
Voices
Sep 7, 2025, 04:53
Luis E. Raez: Very Successful IASLC Latin America Session at WCLC25
Science
Sep 7, 2025, 04:45
Iannis Aifantis: The pre-T Cell Receptor as an Immunotherapy Target in T Cell Leukemia
Voices
Sep 7, 2025, 04:42
Estela Rodriguez Shared Insights on Day 1 of WCLC25
Voices
Sep 7, 2025, 04:32
Elizabeth Mittendorf: Important Discussions on Collaboration to Address the Global Burden of Cancer
Science
Sep 7, 2025, 04:25
Chad Tang: Sequential SBRT for Oligometastatic Clear Cell RCC
Voices
Sep 6, 2025, 22:29
Roberto Borea: ISLB Young Committee's Abstracts Have Been Selected for WCLC25